Table 7. Thirty-day outcomes for patients treated with endovascular approach.
First author | Year | n | Endovascular fenestration | Aortic stenting | Aortic stent-graft | Iliac stent-ing | Technical success | 30-day clinical success | 30-day morbidity | 30-day redo | Date of redo (time post-treatment) | Type of redo | 30-day mortality |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lookstein (16) | 2001 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 GI and liver ischemia | 1 | 36 hours | Exploratory laparotomy | 1 |
Lauterbach (17) | 2001 | 2 | 2 (1 balloon + 1 balloon & iliac stenting) | 0 | 0 | 0 | NS | 2 | 0 | NS | – | – | 0 |
Eggebrecht (20) | 2003 | 1 | 1 (14 mm balloon) | 0 | 0 | 1 | 1 | 0 | ARF and transient HD for reperfusion syndrome | 1 | NS | 1 thoracic aortic stent-graft to seal proximal entry tear | 0 |
Vedantham (21) | 2003 | 7 | 7 | 4 | 0 | 5 | 6 | 5 | NS | NS | – | – | NS |
Fleck (22) | 2004 | 1 | 0 | 0 | 1 (2 talent stent-grafts) | 0 | 1 | 0 | Bowel ischemia and compartment syndrome of lower limb and ARF with temporary dialysis | 1 | 1st and 2nd days | 1 inferior mesenteric artery stenting for bowel ischemia; 1 left lower limb fasciotomy | 0 |
Lorenzen (23) | 2004 | 1 | 0 | 0 | 1 Talent stent-graft | 0 | 1 | 0 | ARF for rhabdo-myolysis and temporary hemodialysis | 1 | 1st, 4th, 6th and 9th days fasciotomies |
3 wound debridements and fasciotomies of right forearm; 1 right forearm amputation | 0 |
Tan (24) | 2004 | 1 | 1 (stenting) | 0 | 0 | 0 | 1 | 1 | 0 | 0 | – | – | 0 |
Yamaghchi (25) | 2006 | 1 | 1 (12 mm balloon) | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 14th day | Adjunctive endovascular fenestration + wall stent deployment | 0 |
Henke (26) (IRAD data)* | 2006 | 8 | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
Henke (26) (local series)* | 2006 | 24 | 18 | 13 | 0 | 12 | NS | NS | NS | NS | NS | NS | NS |
Verhoye (30) | 2008 | 3 | 0 | 0 | 3 | 1 | NS | 2 | NS | NS | – | – | 1 |
Fujita (31) | 2009 | 1 | 0 | 1 (bare metal 10 mm × 57 mm) | 0 | 0 | 1 | 1 | 0 | 0 | – | – | 0 |
Iyer (32) | 2009 | 1 | 0 | 0 | 1 (valiant free-flo) | 0 | 1 | 0 | ARF | 0 | – | – | 0 |
Vulev (35) | 2011 | 1 | 0 | 0 | 1 (valiant) | 0 | 1 | 1 | 0 | 0 | – | – | 0 |
Sfyroereas (36) | 2011 | 10 | 0 | 3 | 10 | 3 | NS | 8 | NS | NS | – | – | 0 |
Narita (38) | 2012 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | Recurrent implanted stent collapse | 1 | 4th and 9th days | 1-adjunctive common iliac stenting. 2-endovascular aortic fenestration with stent deployment | 0 |
Corfield (42) | 2014 | 1 | 0 | 0 | 1 | 1 | NS | 1 | 0 | 0 | – | – | 0 |
Overall | – | 65 | 31/57 (54%) | 21/57 (37%) | 18/57 (32%) | 24/57 (42%) | 15/17 (88%) | 22/33 (67%) | 6/13 (46%) | 6/11 (55%) | – | – | 2/26 (8%) |
*, overlap of 18 patients. NS, not specified; n, number of patients; GI, gastrointestinal; ARF, acute renal failure; HD, hemodialysis.